This Week’s Life Science Headlines

        Litigation Regulatory
Continue reading...

Centralized Status Rejected for Tylenol Liver-Injury Suits

The New Jersey Supreme Court has rejected yet another application — again by a defendant — for centralization under Rule 4:38A.  As we previously noted, Johnson & Johnson earlier this year submitted an application seeking centralization of all suits alleging liver damage from the ingestion of Tylenol in Middlesex County.  J&J’s application came on the heels of the establishment of a federal MDL on the same issue. In a notice dated last month and released last week, the NJ Supreme Court rejected J&J’s request. …
Continue reading...

Tylenol Subject of Latest New Jersey Centralized Management Request

Suits alleging liver damage from acetaminophen are the latest subject of a request for centralized management in New Jersey.  Late last month, McNeil-PPC and Johnson & Johnson submitted an application seeking centralized management of all pending New Jersey lawsuits involving alleged liver damage from Tylenol products. The application, which comes on the heels of the establishment of a federal Multi-District Litigation for similar suits pending in the federal courts, seeks centralization of all New Jersey Tylenol cases in Middlesex County before Judge Mayer, rather than…
Continue reading...